METTL1 and intrahepatic cholangiocarcinoma: Although studies of METTL1 have been limited, overexpression of METTL1 could drive tumor progression which was reported in hepatocellular carcinoma, colon cancer, intrahepatic cholangiocarcinoma, and lung cancer (9–13).